Thailand-Based IVF Clinic Discloses XRP Treasury Holding in SEC Filing
New Gen IVF Group, a medical company based in Thailand, has disclosed XRP holdings on its balance sheet through an SEC filing, purchasing approximately 146,000 units of XRP in 2025 as part of a broader digital asset treasury strategy. The filing places XRP alongside Bitcoin, Ethereum, and Solana in the company's portfolio, representing a notable example of corporate XRP adoption outside the technology sector.
A Thailand-based fertility clinic, New Gen IVF Group, has formally disclosed exposure to XRP in an SEC filing, marking an unusual instance of a healthcare company adding XRP to its corporate treasury. The disclosure was made via an F1 amendment and confirms the purchase of approximately 146,000 XRP in 2025.
The company's digital asset strategy is not limited to XRP. The filing indicates holdings alongside Bitcoin, Ethereum, and Solana, suggesting a diversified approach to corporate crypto treasury management. XRP's inclusion in a non-technology, non-finance company's balance sheet is notable given that most corporate crypto adoption has historically been concentrated in tech-adjacent firms.
- Company: New Gen IVF Group (Thailand)
- Asset disclosed: XRP, alongside Bitcoin, Ethereum, and Solana
- Approximate XRP purchased: 146,000 units in 2025
- Disclosure vehicle: SEC F1 amendment filing
This filing adds to a growing body of evidence that XRP is being considered as a legitimate treasury asset by companies in sectors well outside crypto's traditional orbit. Healthcare adoption of this kind, while small in scale, may indicate that the use case for XRP as a treasury reserve is broadening.
Key facts
- •New Gen IVF Group is a Thailand-based medical company
- •Company disclosed XRP holdings via an SEC F1 amendment
- •Approximately 146,000 XRP purchased in 2025
- •XRP held alongside Bitcoin, Ethereum, and Solana
- •Represents corporate XRP adoption in the healthcare sector